Endocrine therapy. CDK4/6 inhibition. TKIs.
This clip connects PATINA and HER2CLIMB-05 to real-world maintenance decisions — and why hormone receptor status still matters in HER2+ disease.
PATINA & HER2CLIMB-05: Rethinking Maintenance Therapy
You may also like
Recommended Videos
